[Ip-health] Oxfam statement on Novartis case
mkamalyanni at oxfam.org.uk
Sun Sep 4 08:53:14 PDT 2011
Oxfam is closely watching the outcome of Novartis' endless and highly
damaging challenge to Section 3(d) of India's Patent Act. We are
profoundly disappointed that Novartis has continued to pursue legal action
against the Indian Government. Five years ago, hundreds of thousands of
people called upon Novartis to drop its legal challenge against the
Indian. Today, over 2 billion people still lack regular access to
affordable medicines, and yet Novartis has persisted. Oxfam is seriously
concerned that if Novartis succeeds, it will lead to long term and
profound changes in India's patent system that will undermine generic
competition and access to affordable, low-cost medicines.
Mohga - A Proud Egyptian-Dictating to the computer so please forgive silly
Dr. Mohga M Kamal-Yanni
Senior health & HIV policy advisor
John Smith Drive, Oxford, OX4 2JY, UK
Tel: + 44 (0) 1865 472290
Fax + 44 (0) 1865 472245
Mobile + 44 (0)777 62 55 884
Skype Mohga Kamal-Yanni
Oxfam works with others to overcome poverty and suffering.
Oxfam GB is a member of Oxfam International and a company limited by guarantee registered in England No. 612172.
Registered office: Oxfam House, John Smith Drive, Cowley, Oxford, OX4 2JY.
A registered charity in England and Wales (no 202918) and Scotland (SC 039042)
More information about the Ip-health